JACN Did you know that you can get alerts when a new issue is online?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grahn, B. H.
Right arrow Articles by Zhang, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grahn, B. H.
Right arrow Articles by Zhang, Z.
Journal of the American College of Nutrition, Vol. 20, No. 2, 106-118 (2001)
Published by the American College of Nutrition


Review

Zinc and the Eye

Bruce H. Grahn, DVM, Phyllis G. Paterson, PhD, Katherine T. Gottschall-Pass, PhD and Zhen Zhang, MSc

Department of Small Animal Clinical Sciences, Western College of Veterinary Medicine B.H.G.), CANADA
College of Pharmacy and Nutrition (P.G.P., Z.Z.), University of Saskatchewan, Saskatoon, Saskatchewan, CANADA
Department of Family and Nutritional Sciences, University of Prince Edward Island, Charlottetown, Prince Edward Island (K.T.G.-P.), CANADA

Address reprint requests to: Bruce H. Grahn, D.V.M., Department of Small Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon S7N 5C9, CANADA. E-mail: Bruce.Grahn{at}usask.ca


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 LOCALIZATION AND CONCENTRATION...
 ELECTROPHYSIOLOGIC, GROSS AND...
 ZINC SUPPLEMENTATION AND...
 THE FUNCTIONS OF ZINC...
 CONCLUSIONS
 REFERENCES
 
Zinc, a trace element that influences cell metabolism through a variety of mechanisms, appears to play an integral role in maintaining normal ocular function. This element is present in high concentrations in ocular tissue, particularly in retina and choroid. Zinc deficiency has been shown in a number of species to result in a variety of gross, ultrastructural and electrophysiologic ocular manifestations. The physiological functions for zinc have been studied predominantly in retina and retinal pigment epithelium where zinc is believed to interact with taurine and vitamin A, modify photoreceptor plasma membranes, regulate the light-rhodopsin reaction, modulate synaptic transmission and serve as an antioxidant. Suboptimal zinc status in North America may influence the development and progression of several chronic eye diseases. Zinc supplementation trials and epidemiological studies have produced conflicting results concerning the role of zinc in age-related macular degeneration. Additional well-controlled supplementation trials are indicated to clarify the role of zinc in this disease. Future investigations must also expand our understanding of the mechanisms by which zinc regulates ocular morphology and function.

Key words: zinc, eye, retina, age-related macular degeneration

Abbreviations: RPE=retinal pigment epithelium • ARMD=age-related macular degeneration • ERG=electroretinogram • OP=oscillatory potential

Key teaching points:

• There is a substantial concentration of zinc in the eye, particularly in the retina, retinal pigment epithelium and choroid of most species of animals

• The ocular manifestations of zinc deficiency include altered vision, electroretinograms, and oscillatory potentials, and, if the deficiency is severe, ultrastructural changes are detected in the retina and retinal pigment epithelium

• Zinc supplementation may alter the progression of some degenerative retinal diseases

• The known functions of zinc in the retina and retinal pigment epithelium include modification of synaptic transmission, regulation of the light rhodopsin reaction, interactions with taurine and vitamin A, modifier of photoreceptor plasma membranes and antioxidant.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 LOCALIZATION AND CONCENTRATION...
 ELECTROPHYSIOLOGIC, GROSS AND...
 ZINC SUPPLEMENTATION AND...
 THE FUNCTIONS OF ZINC...
 CONCLUSIONS
 REFERENCES
 
Zinc has been recognized as an essential element for plants and animals for over 60 years [1]. It is the second most abundant trace element in the human body, and the total content is approximately two grams [2,3]. This element is absorbed by the enterocytes in the proximal small intestine, and it is excreted predominately through the gastrointestinal system, with minor amounts being lost through the skin and urinary system [4,5]. Zinc in plasma is bound primarily to albumen and {alpha}2-macroglobulin, with a small percentage bound to low molecular weight substances such as histidine and cysteine [6]. Until recently, the mechanism of zinc transport by many tissues including enterocytes has been poorly understood. Although differences exist among different cell types, there appears to be both saturable and nonsaturable components to the transport process [7]. There may also be an energy requirement for some aspects of zinc transport [7]. Several proteins directly associated with zinc transport have been described in the last decade, and the family of known zinc transporters has recently beenreviewed [7]. Once these transporters have been completely described, we will have a better basis for understanding zinc absorption and homeostasis.

Most zinc in the body is intracellular; the largest pools in adults are in the muscle, bone, skin, hair and liver [2]. Most of the intracellular zinc is stable and does not respond to zinc deprivation. In addition to the plasma zinc pool, the small labileportion in the liver might provide some small reserve during deficiency [2]. Thus, a regular adequate dietary supply of zinc is needed. The metallothioneins, a family of intracellular zinc-binding proteins, have been proposed as playing an important role in controlling whole body zinc metabolism [6,8]. Although severe zinc deficiency is relatively rare in North America, moderate zinc deficiency has been associated with malabsorption syndromes, alcoholism, chronic renal disease and chronic debilitating diseases [1,5]. It is estimated that a milder deficiency presenting with growth retardation or altered taste and olfaction is also relatively widespread in healthy individuals, including the elderly [2,5]. The diagnosis of zinc deficiency is difficult due to the lack of a single specific and sensitive biochemical index of zinc status. The most reliable method for diagnosing marginal zinc deficiency in humans is considered to be a positive response to zinc supplementation. An alternative approach is to use a combination of biochemical and functional tests to evaluate zinc status. Serum or plasma zinc on its own is neither sensitive nor specific. A number of comprehensive reviews have been published on the subject of assessing zinc status in the human population [913].

Zinc functions in a multitude of physiologic roles. The clinical manifestations of zinc deficiency depend upon the severity of the deficiency, but the classic features include anorexia, retarded growth, weight loss, impaired immune function, delayed sexual maturation, testicular atrophy, epidermal hyperkeratinization, alopecia, hypogeusia and night blindness [2]. The nonspecificity of these features supports the fundamental role of zinc in cell metabolism [2]. The major biochemical functions of zinc include its catalytic or structural role in at least 300 zinc metalloenzymes, a structural role in a large number of transcription factors and a role in the maintenance of plasma membrane function [6,14,15].

The concentration of zinc in ocular tissues is unusually high when compared to other tissues [16]. The descending order of zinc concentration in human ocular tissues is retina and choroid, ciliary body, iris, optic nerve, sclera, cornea, and lens [3]. These unusually high concentrations and conflicting reports of zinc status and vision loss in macular degeneration [17,18] have lead to a wealth of recent research. There are only a few reviews of zinc and the eye, and they were published almost two decades ago [3,19]. The purpose of this paper is to review the ocular manifestations of zinc deficiency, localization and concentration of zinc in the eye and proposed functions of this element in the retina and retinal pigment epithelium (RPE).


    LOCALIZATION AND CONCENTRATION OF ZINC IN THE EYE
 TOP
 ABSTRACT
 INTRODUCTION
 LOCALIZATION AND CONCENTRATION...
 ELECTROPHYSIOLOGIC, GROSS AND...
 ZINC SUPPLEMENTATION AND...
 THE FUNCTIONS OF ZINC...
 CONCLUSIONS
 REFERENCES
 
Zinc has been localized in tissues by several methods. Histochemistry has been extensively used and the methodologies include dithizone [20] and Timm’s sulphide silver methods [21,22]. The dithizone method, although it is more specific for zinc, it is less sensitive for localization than Timm’s method [23]. The original Timm’s method has been modified to reduce morphological damage during processing, yet maintain sensitivity. This technique is called the Neo-Timm method [24]. Wu et al. have utilized this modified method and localized zinc in vertebrate photoreceptors [25]. Immunohistochemical and biochemical localization of metallothionein is not specific for zinc. However, both techniques have been used successfully to investigate some of the intracellular roles of this trace element [26,27]. Energy dispersive x-ray microanalysis has also been used to map zinc in the RPE [28] and has revealed decreased amounts of zinc in melanosomes of degenerating RPE cells [29]. Similarly, Samuelson et al. have used the X-ray microprobe to document age-related changes in the zinc content of the RPE in sheep with ceroid-lipofuscinosis [30] and in the choroid of pigs [31]. The fluorescent probe zinquin has been utilized to study intracellular zinc in thymocytes, splenocytes [32] and hepatocytes [33]. Although this technique has not been reported in the eye, it may be useful in future studies to localize zinc accurately at a cellular level in ocular tissues.

Zinc has been localized in the photoreceptors of rats and cattle [34,35]. When rats were fed zinc-deficient diets, a weaker histochemical was displayed within the photoreceptors, suggesting a decreased zinc content in the outer segments [20]. Neo-Timm staining of the retinas of larval tiger salamanders has revealed that a significant concentration of zinc is also present in the outer nuclear layer [25].

In vivo and in vitro studies have identified substantial amounts of zinc in the choroid and the RPE [21,22,31,36,37] that alter retinal and RPE morphology [38,39], and both of these tissues are important in the uptake of zinc within the eye [40,41,42]. Zinc is also present in the tapetum lucidum of the cat and dog and, more specifically, in the periphery of the tapetal rods, between the tapetal rod and its membrane [21,22,36].

Zinc concentration in ocular tissues has been determined by flame or flameless atomic absorption spectrophotometry [37,4352], neutron activation [53,54], X-ray fluorescence [16], electron probe microanalysis [55], inductively coupled plasma-mass spectrometry [56,57] and plasma emission spectrophotometry [58]. The amount of zinc varies greatly with age and the ocular tissue examined; however, the retina and uvea usually contain the highest concentrations (Table 1) [16,37,52,53,56,57,5962]. A number of investigators have reported an increase in zinc concentration in cataractous lenses [49,50,63], and cataracts have been associated with zinc deficiency in fish [6467]. The zinc concentration is consistent throughout the normal rabbit lens, despite higher activity of superoxide dismutase, a zinc-dependent metalloenzyme, in the anterior lenticular segment [52,68]. Bentley et al. have characterized zinc exchange in the rabbit lens [68]. Although cornea and aqueous humor zinc concentration declined in the zinc deficient rabbit, these investigators found no change in the zinc concentration of the lens [52]. In contrast, we reported a significant decline in lens zinc concentration in the zinc-deficient rat [57]. This series of reports linking zinc to the lens suggests that the physiologic function of zinc in the lens should be explored as well as the impact of zinc deficiency on cataract development.


View this table:
[in this window]
[in a new window]
 
Table 1. Mean zinc concentration (µg/g dry wt) in ocular tissues of varied species

 

    ELECTROPHYSIOLOGIC, GROSS AND ULTRASTRUCTURAL OCULAR MANIFESTATIONS OF ZINC DEFICIENCY
 TOP
 ABSTRACT
 INTRODUCTION
 LOCALIZATION AND CONCENTRATION...
 ELECTROPHYSIOLOGIC, GROSS AND...
 ZINC SUPPLEMENTATION AND...
 THE FUNCTIONS OF ZINC...
 CONCLUSIONS
 REFERENCES
 
The manifestations of zinc deficiency and diseases associated with low serum zinc are subtle and easy to confuse with those of other eye diseases. These manifestations have been described in rats, cats, dogs, pigs, fish, primates and humans.

Rats
Zinc deficiency in this species dramatically affects ocular development. Severe zinc deficiency, when imposed on rats during gestation, resulted in optic cup invagination failure, colobomata, retinal dysplasia and occasionally anophthalmia in the pups [69,70]. We reported significant retinal dysplasia and depression of the electroretinograms in rats born to dams that were marginally zinc- and taurine-deficient throughout gestation and postnatal life until 7.5 to 8.5 weeks of age [71,72]. These studies indicate that zinc is essential for normal ocular development. When zinc deficiency was imposed at parturition in rats, eyelid opening was delayed; however, morphological changes were not noted in the photoreceptor cells at weaning [73]. Marginal zinc deficiency imposed in our postnatal rat model also failed to produce morphologic ocular changes despite depression of the electroretinogram and oscillatory potentials [74]. Weanling male Sprague-Dawley rats that were maintained for seven weeks on a severely zinc deficient diet did not develop gross ocular manifestations of zinc deficiency. However, they did display retarded growth, alopecia and scaly epidermis and keratitis, and electron microscopy confirmed degeneration of the photoreceptor outer segments and osmiophilic inclusion bodies in the RPE [7578].

Cats, Dogs, Pigs and Fish
An inherited tapetal abnormality has been reported in the dog and cat, in which the tapetal rods contain significantly less zinc than those of control animals. The clinical manifestations included a lack of tapetal development [36,62,79]. Jacobsen et al. fed cats diets that were marginally deficient in zinc (<7 ppm zinc) for four months. They reported reduced weight gain and, although no other morphologic changes were described in these cats, documented inconsistent reductions in the b-wave amplitude of the electroretinogram, which were reversible with zinc repletion [80]. Robertson and Burns reported that dogs fed a zinc-deficient diet containing excess calcium developed conjunctivitis, ocular discharge and keratitis [81]. Samuelson et al. have reported ultrastructural changes in the RPE and choroidal melanocytes of adult pigs when they were maintained on diets deficient in zinc. These included displacement of cone nuclei towards the RPE, swollen outer segments of photoreceptors and altered choroidal melanosomes [31,38,39,82,83]. Cataracts and exophthalmos have been reported in trout and salmon associated with zinc deficiency [6467].

Humans and Other Primates
Most of the ocular diseases in humans and primates that are associated with zinc deficiency have their pathogenesis linked by decreased serum zinc or by improvement after zinc supplementation and only occasionally by reduced tissue zinc concentrations. Retinas from cynamolgus monkeys with early onset macular degeneration, manifested by drusen and lipofuscin spots, are reported to contain four-fold less zinc and decreased expression of the metallothionein gene as compared to normal monkeys [84]. Olin reported that 47% of a population of aging Rhesus macaques examined had macular drusen; although copper-associated enzymes were the more likely to be associated, serum zinc levels also tended to be lower in monkeys with greater than 10 drusen/fundi [85].

Acrodermatitis enteropathica is a rare early childhood disease, with multiple systemic manifestations caused by an abnormality in zinc metabolism. The ocular abnormalities include blepharitis, photophobia, conjunctivitis, corneal opacities and cataracts [8689]. Superficial punctate opacities, nebulous subepithelial opacities and linear corneal erosions have also been reported in cases of acrodermatitis enteropathica [8690]. Gene expression in acrodermatitis enteropathica has been recently investigated with differential display, and it appears that there may be an insertional mutation affecting mRNA of a zinc transport protein, which results in decreased zinc absorption [91]. Recalcitrant corneal ulcers have been reported in conjunction with low serum zinc [92]. In addition, zinc has been linked indirectly with corneal ulcers because it may be required for functional activity of collagenases [93].

Cherry-red maculopathy and visual impairment have been reported in men with Crohn’s disease and zinc deficiency, and the visual function in some patients improves with zinc supplementation [94,95]. Decreased serum zinc has been documented in patients with retinitis pigmentosa [96]. Increased fecal zinc and decreased granulocyte zinc have been described with desferrioxamine use in thalassaemia [97]. Patients receiving long-term total parenteral nutrition have been reported with altered visual function and decreased plasma zinc concentrations [98]. Similarly, abnormal dark adaptation and diminished scotopic retinal responses are associated with zinc deficiency in alcoholism and hepatic cirrhosis. These conditions often respond to zinc supplementation, but also may require supplemental vitamin A [99105]. While all these studies have advanced the concept of a role for zinc in ocular function, they are complicated by the co-existence of other nutrient deficiencies.

Given the subtle and non-specific ocular manifestations associated with zinc deficiency, the clinical diagnosis is difficult. More importantly, the marginal zinc deficiency associated with chronic diseases may affect the eye by interactions with other key elements, toxins or other diseases, and the clinical signs may not manifest for prolonged periods of time [106110].


    ZINC SUPPLEMENTATION AND DEGENERATIVE EYE DISEASES
 TOP
 ABSTRACT
 INTRODUCTION
 LOCALIZATION AND CONCENTRATION...
 ELECTROPHYSIOLOGIC, GROSS AND...
 ZINC SUPPLEMENTATION AND...
 THE FUNCTIONS OF ZINC...
 CONCLUSIONS
 REFERENCES
 
Age-related macular degeneration (ARMD) is a leading cause of blindness in elderly humans, and the sensory retina and RPE are directly involved in the pathogenesis of this disease. For the past two decades there has been considerable interest and controversy related to zinc supplementation of patients with ARMD. In 1988, Newsome et al. reported significantly less visual loss in patients with ARMD when they were supplemented with 81 mg of oral zinc daily over a two-year period [18]. Conversely, four years later, the Eye Diseases Case-Control Study Group reported no association between serum zinc levels and risk of ARMD [17]. This was not unexpected given the unreliability of serum zinc as an indicator of total body or retinal zinc concentrations. Ophthalmologists and optometrists continued to advise zinc and other antioxidant supplementation at 100% of the recommended dietary allowance for patients with some retinal degenerations [111].

Recent studies have not clarified the issue of the need for zinc supplementation of patients with degenerative retinal diseases any further. Stur et al. reported a double masked, randomised placebo controlled study that failed to show any effect of zinc supplementation in patients who had an exudative form of ARMD in one eye [112]. Subsequently, Mares-Perlman et al. reported that dietary zinc was weakly protective in the development of early ARMD [113]. In contrast, the Blue Mountains Eye Study failed to document any association between ARMD and intake of zinc from diet or supplements [114]. A recent prospective population-based cohort study demonstrated no relationship between incidence of early ARMD and dietary intake of zinc, whereas a modest inverse association was observed between dietary zinc and development of retinal pigmentary abnormalities [115]. The inconsistencies among these studies could be due to differences in study design, specificity of macular lesions, stage of the disease and methods for assessing dietary zinc intake or status [115].

Further intervention studies are required to establish firm criteria for zinc supplementation aimed at preventing some degenerative retinal diseases [116]. Some authors caution against widespread oral zinc supplementation of humans with ARMD [117]. It is important to stress that the pathogenesis of ARMD is complex and involves multiple genetic, toxic and perhaps nutritional factors. The determination of nutrition influences will require an innovative supplementation study. Such a study is being attempted currently in North America, with the objective to clarify the progression of ARMD with and without supplementation of multi-vitamins, minerals and antioxidants [118]. The prevention of ARMD in most patients in the future will likely involve pharmacologic, genetic and nutritional interventions to change the primary biochemical abnormalities [119].

While numerous studies have documented a relationship between zinc and diabetes mellitus, there are few studies that have investigated the potential link between zinc status and the development of diabetic retinopathy. Chausmer (120) has reviewed the complex interactions between zinc and diabetes. Not only can diabetes disturb zinc homeostasis, mainly through increased urinary zinc loss, but zinc status may also influence insulin action and the development of diabetes mellitus and its chronic complications. Faure et al. (121) suggested that there was a protective effect of zinc supplementation on markers of oxidative stress in patients with diabetic retinopathy. Zinc deficiency and supplementation studies in animal models will be required to unravel the role of zinc in the complex pathogenesis of this and other ocular conditions.


    THE FUNCTIONS OF ZINC IN THE RETINA AND RPE
 TOP
 ABSTRACT
 INTRODUCTION
 LOCALIZATION AND CONCENTRATION...
 ELECTROPHYSIOLOGIC, GROSS AND...
 ZINC SUPPLEMENTATION AND...
 THE FUNCTIONS OF ZINC...
 CONCLUSIONS
 REFERENCES
 
Some of the functions that zinc plays in the retina and RPE have been described. The functions of zinc in the cornea, sclera, lens and uvea have not been reported.

Retina
Zinc is highly concentrated in the retina [37]. Despite a number of electrophysiologic changes noted in mild dietary zinc deficiency in rats [71,72,74], we have not detected a decline in retinal zinc concentration by inductively coupled plasma-mass spectrometry [57]. However, there may be an intracellular shift of zinc which may be significant in terms of function [6]. As previously described, zinc has been mapped to specific retinal regions with histochemistry. Using dithizone, zinc was detected only in rat photoreceptor outer segments, and the staining was reduced in zinc deficiency [20]. The histochemical approaches have limitations in mapping zinc throughout the retina as they can measure only loosely bound zinc [23]. However, this may be the important pool since tightly bound zinc appears to be well-preserved under many zinc deficiency conditions. The results of our studies suggest that effects of zinc are not confined to the photoreceptors, but also extend to inner retinal neurons since zinc deficiency depressed specific oscillatory potentials as well as the b-wave of the electroretinogram (ERG) [71,72,74].

Our studies also revealed that mild zinc deficiency present during prenatal and postnatal life substantially worsened the retinal degeneration observed in the taurine-deficient rat [71,72,74]. When the zinc and taurine deficiencies were combined, retinal dysplasia was documented in the pre-natal model only [71]. Zinc deficiency imposed throughout pre- and postnatal retinal development depresses the ERG, and zinc acts synergistically with taurine in inducing these effects [71,72]. Deficiencies of zinc or taurine also independently depressed the a- and b-waves of the ERG [72]. Vmax represents the maximum amplitude obtained when the wave amplitude is plotted as a function of light intensity [122]. Vmax for the b-wave was decreased, in our studies, suggesting a decrease in the area of functioning retina [72]. Zinc deficiency independently depressed the amplitude of the first oscillatory potential (OP1), but depressed OP2 and OP3 only when the rats were also taurine-deficient [71]. We subsequently evaluated the retinal response to suboptimal zinc supply imposed during the postnatal period until after the retina reached maturity in rats [74]. Zinc deficiency caused a decline in the amplitude of OP1, OP3, OP4 and OP5 and decreased the amplitude of the a- and b- waves of the ERG [74]. The nature of the interaction with taurine differed from that seen in the first study [71].

Our results support an earlier study which revealed that zinc and taurine interact in the retina in vitro [123]. Jacobsen et al. also reported an elevated dark-adapted ERG threshold in zinc-deficient cats that was reversible with zinc supplementation. The rod-mediated electroretinograms from the cats with zinc deficiency differed from those of cats with taurine deficiency [80]. These studies demonstrate that mild zinc deficiency, consistent with that which may occur in selected human populations, produces detrimental functional consequences in the retina.

A number of hypotheses have been offered to explain the mechanism of action of zinc in the retina, including its role in zinc metalloenzymes. While there are a vast number of zinc metalloenzymes, only a few have been shown in other tissues to have reduced activity in response to zinc deficiency, and this is likely because the zinc is tightly bound to the metalloenzyme [6]. Convincing correlations between changes in the activity of specific zinc metalloenzymes and the pathology of zinc deficiency are also lacking. Therefore we suggest that alternate mechanisms appear more viable in explaining the functional activity of zinc in retina.

It has been proposed that zinc exerts an effect on retinal function through its involvement in vitamin A metabolism. Smith has reviewed the complex and controversial interaction between zinc and vitamin A [124]. Impaired dark adaptation reported in human zinc deficiency [99,125] has been thought to occur due to decreased rhodopsin formation [126]. Conflicting results have been obtained in severely zinc-deficient rats as to whether this is a consequence of a decreased rate of oxidation of retinol to retinal by a zinc-dependent alcohol dehydrogenase [124,126128]. It has become apparent that much of the effect of zinc on this enzyme can be attributed to the depressed food intake and growth retardation associated with severe zinc deficiency [124]. These studies highlight the importance of including pair-fed controls in animal studies of zinc deficiency. Zinc deficiency also depresses plasma and liver retinol binding protein concentrations, which could result in a failure to mobilize vitamin A from liver stores [124,129]. The impact of the latter on vitamin A metabolism in the retina has not been studied. It has been proposed that zinc deficiency must be of a severe nature to impair vitamin A metabolism at the cellular level [124]. An independent role for zinc in retinal function was suggested by a study in which supplementation of both zinc and vitamin A was necessary for the greatest improvement in the electroretinogram of rats deficient in both nutrients [130]. Christian and West have also concluded in a recent review that there remains to be established evidence of an interaction between zinc and vitamin A of proven health significance in humans [131]. Since our prenatal model [71,72] has shown depressed retinal function in mild zinc deficiency in the absence of depressed growth, we suggest that other functions of zinc in the retina exist and should be explored further.

Zinc is important in plasma membrane function through its effects membrane protein conformation and protein-protein interactions [6]. This may be a critical function for zinc in the outer segments of photoreceptors. The discs, comprising stacks of double membranes, are derived through constant growth of the plasma membrane [132]. Loss of zinc from disc proteins that control disc shedding, or maintain structure, may compromise membrane integrity and depress the ERG. Zinc is a normal component of the disc membrane that can be measured by particle-induced X-ray emission [133]. It has been reported that zinc is associated with rod outer segment proteins and that increased amounts were present when the samples were photobleached [34]. Takahashi et al. have also reported a nonuniform subcellular distribution of zinc, with the largest amounts found in the rod outer segments and also in the photoreceptor cell synaptosomes [134]. A metallothionein-like protein may function in transport and compartmentalization of zinc within the retina [134].

Another particularly attractive hypothesis is that of Shuster et al., who suggest that zinc might help to stabilize the light-activated protein, rhodopsin, or modulate reactions that are initiated by light [135]. Zinc was first found to alter binding of azido-({alpha}32P)ATP to rhodopsin [136]. Subsequently zinc was shown to bind detergent-solubilized rhodopsin and enhance rhodopsin phosphorylation at micromolar concentrations [35]. The latter is important for initiating quenching of the light response [135]. The work of Shuster et al. suggests that this effect of zinc appears to occur through an effect on the substrate rather than by enhancing rhodopsin kinase or depressing phosphatase activity [135]. In contrast, studies by Ou et al. suggest that metallothionein in bovine retina can donate zinc to activate protein kinase C which can phosphorylate rhodopsin [137]. Zinc deficiency in humans has also been shown to alter dark adaptation [99,125]. These studies suggest that zinc is associated with the primary photochemical event. This is further supported by a recent report that the localization of histochemically visualized zinc shifts when rat retinas are dark- or light-adapted [138]. These investigators found chelatable zinc in the dark-adapted retina to be primarily associated with the RPE cells and photoreceptor perikarya and some of the perikarya of the inner nuclear layer, both plexiform layers and the ganglion cell layer. When the retina was light adapted, the chelatable zinc was detectable in the inner segments of the photoreceptors only. It was suggested that during light adaptation, zinc may be translocated from the perikarya into the inner and outer segments, but that the zinc in the outer segments was not visualized histochemically because of binding to molecules like rhodopsin [138]. It has also been suggested that an alteration in retinal zinc metabolism may be responsible for the rhodopsin loss seen in fetal alchohol syndrome [139].

Neo-Timm staining also shows zinc to be concentrated in the synaptic terminal regions of photoreceptors, where it has been suggested to function as a modulator of synaptic transmission [25,140]. Zinc and cadmium preferentially occupy open channels in salamander rods and the divalent cations Ni2, Cd2, Zn2 and Mn2 potentiate the activity of cGMP by more than threefold in the outer segments [141]. Using larval tiger salamanders, Wu et al. localized zinc ions within glutamatergic synaptic vesicles in the base of inner segments of the photoreceptors and postulated that zinc was a diffusable switch that regulated neurotransmitter signalling in the outer retina [25]. In addition, they demonstrated that Zn2+ blocks the depolarizing effects of GABA in horizontal cells and suggested that both rod and cone photoreceptors use vesicular Zn2+ to modify the response of the first retinal synapse [25]. Subsequently, Qian et al. documented GABAa in glial cells of the Skate and bipolar cells of Bass and reported that zinc enhanced the response to GABA significantly in these cells [140,142144]. Zinc has also been shown to inhibit the GABAc response of bipolar cells of bass and the horizontal cells of catfish [140, 142147]. Shen and Yang reported that low concentrations of zinc stimulated AMPA receptors of carp retinal horizontal cells while higher concentrations inhibited the same response [148].

Zinc may also serve a critical function as an antioxidant in the retina. Although zinc appears to act as an antioxidant in in vitro systems, the specific antioxidant functions for zinc in vivo have not been identified in other tissues [149] and have generally not been studied in the retina. One in vitro study utilizing rod outer segments of frogs showed a significant protective effect by zinc and taurine against peroxidative damage induced by ferrous sulfate [123]. What is striking in other tissues is that zinc-deficient animals are less able to tolerate an increase in oxidative stress, as has been shown in lung exposed to hyperoxia [149,150]. The photoreceptors are particularly susceptible to oxidative damage because of their high polyunsaturated fatty acid content, high metabolic rate and constant bombardment by light [151]. The retina also has relatively low peroxide scavenging capabilities as shown by low glutathione concentration and glutathione peroxidase activity [152,153]. These properties in addition to its high zinc concentration suggest that the retina may be an ideal tissue in which to study the antioxidant functions of zinc.

Retinal Pigment Epithelium
Zinc is also highly concentrated in this cell layer [29], and the concentration decreases during periods of zinc deficiency [31]. Previous data in the pig and rat are conflicting as to whether the morphologic damage associated with zinc deficiency develops first in the neural retina or occurs secondary to alterations in the retinal pigment epithelium [39,77]. The RPE appears to be a significant cell that maintains retinal zinc pools during dietary deficiency. Studies in our laboratories reveal that retinal zinc concentrations are conserved in marginal zinc deficiency in the rat despite significant decreases in serum, liver and bone zinc concentrations [57]. Leure-duPree gave zinc chelators intra-peritoneally and produced RPE electron opaque inclusions. They concluded that sequestration of zinc in Spraque-Dawley rats resulted in pronounced effects on the RPE [75]. They provided further evidence that these effects were specific to zinc deficiency in their subsequent report of marked ultrastructural abnormalities, including deep basal infolding of the RPE, vesiculation and degeneration of the rod outer segments in rats maintained on severely zinc deficient diets [76,77].

Newsome and Rothman have documented zinc uptake by human RPE in vitro by what appears to be facilitated transport [41]. Newsome et al. demonstrated uptake and retention by RPE and other ocular tissues in rhesus monkeys when 65Zn was administered intravenously or orally [42]. Zinc sulfate concentrations ranging from 0.5 to 5 mM have been shown to activate alpha-mannosidase by twofold when added to human RPE cell cultures [154]. Alpha-mannosidase is concentrated in the RPE and is likely a key enzyme that digests thousands of effete disc membranes each day. Oliver et al. have confirmed the expression of metallothionein in cultured human RPE cells and have shown that its induction is associated with increased capacity for 65Zn uptake in these cells [40]. The presence of metallothionein in the RPE of rats has also been demonstrated by immunohistochemistry [26]. Tate et al. determined that the macular region contains significantly less zinc and metallothionein than the peripheral RPE and that macular RPE metallothionein decreases significantly in patients older than 70 years of age [27]. Culturing human RPE cells in low zinc media resulted in a reduction in metallothionein and zinc concentration, decreased cell proliferation, reduced protein production and decreased activity of catalase, alkaline phosphatase and alpha-mannosidase [155]. The decrease in catalase activity was unexpected since it is not a zinc-dependent enzyme. A follow-up study of zinc supplementation in cultured fetal RPE cells suggested that zinc may play a role in transcriptional regulation of catalase [156]. Subsequent research by this group revealed that human RPE cells cultured in low zinc medium were more susceptible to oxidative insult induced by H2O2 and paraquat [157]. This was shown by an increase in conjugated dienes, thiobarbituric acid reactive substances and protein carbonyls which was coincident with a decrease in catalase activity and reduced metallothionein concentration. In dietary zinc deficiency in pigmented rats, these researchers reported the depression in metallothionein concentration seen in their RPE culture studies, but no change in catalase activity. An increase in retinal oxidative stress was also evident as measured by thiobarbituric acid reactive substances [158]. While they also suggested that dietary zinc deficiency decreases neuroretinal zinc, their data were presented as total retinal zinc; this makes it difficult to interpret whether the decrease is due to zinc deficiency or the smaller size of the retina since zinc deficiency causes growth retardation.

While the mechanism by which zinc serves as an antioxidant in any tissue is uncertain [149], one indirect role of zinc in RPE cells may be its ability to induce the synthesis of metallothionein, which may scavenge hydroxyl radicals [159].

In summary, a number of potential mechanisms have been put forward by which zinc may play a central role in the function of the retina and RPE. These are mainly based on in vitro studies in which zinc has been added in concentrations ranging from physiological to pharmacological. These mechanisms should be further explored in zinc-deficient animal models to determine which of the biochemical functions can account for the altered retinal physiology associated with zinc deficiency.


    CONCLUSIONS
 TOP
 ABSTRACT
 INTRODUCTION
 LOCALIZATION AND CONCENTRATION...
 ELECTROPHYSIOLOGIC, GROSS AND...
 ZINC SUPPLEMENTATION AND...
 THE FUNCTIONS OF ZINC...
 CONCLUSIONS
 REFERENCES
 
Karcioglu in 1982 described the knowledge about zinc metabolism in the eye as fragmentary and quite confusing [3]. Almost two decades later, this statement is still appropriate. Much of the evidence for the role of zinc in retinal function comes from interaction studies with other nutrients, a few naturally occurring diseases and many in vitro studies. This research reveals that zinc has several important functions in the retina and RPE (Fig. 1). Zinc interacts with taurine and vitamin A in the retina, modifies plasma membranes in the photoreceptors, regulates the light-rhodopsin reaction within the photoreceptor, modulates synaptic transmission and serves as an antioxidant in both the RPE and retina.



View larger version (77K):
[in this window]
[in a new window]
 
Fig. 1. Functions of zinc in the retina and retinal pigment epithelium.

 
Recent research has revealed that zinc may affect several degenerative neurologic diseases and these mechanisms may have implications for human eye diseases. Well-designed supplementation studies may demonstrate specific benefits. Zinc supplementation has been reported to decrease the aging process in mice [160]. Carmody et al. have recently reported that zinc chloride reduces apoptotic photoreceptor death in an in vitro model of retinitis pigmentosa [161]. Low concentrations of zinc have been shown to be neuroprotective in the retina, while larger concentrations have a negative effect [162]. Another note of caution in selecting the dose for supplementation studies is that excessive intakes of zinc can cause secondary copper deficiency because of the interaction between these two trace elements [4]. Zinc deficiency has been suggested to occur in Parkinson’s disease and may be specifically related to the vision, olfactory and taste loss in these patients [163]. Zinc is also effective in blocking genes that encode for inflammatory cytokines, including IL-6 in endothelial cells, and this strongly supports the supposition that adequate zinc nutrition may protect against many inflammatory diseases, including atherosclerosis, by inhibiting the activation of oxidative stress-responsive transcription factors and the expression of inflammatory cytokines [164]. Zinc deficiency is also being linked to aging and age-related degenerative diseases which manifest with an increase in the copper/zinc ratio and systemic oxidative stress in general [165].

A complete picture of the many mechanisms by which zinc influences cell metabolism is still being explored. Future investigations must address these mechanisms in the eye as a means of understanding the role of zinc in ocular function and degenerative eye diseases.


    ACKNOWLEDGMENTS
 
PG Paterson thanks the Hospital for Sick Children Foundation (XG 93-002) and the Natural Sciences and Engineering Research Council of Canada for research support.

Received May 22, 2000. Accepted December 5, 2000.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 LOCALIZATION AND CONCENTRATION...
 ELECTROPHYSIOLOGIC, GROSS AND...
 ZINC SUPPLEMENTATION AND...
 THE FUNCTIONS OF ZINC...
 CONCLUSIONS
 REFERENCES
 

  1. Prasad AS: Zinc: an overview. Nutrition 11: 93–99, 1995.[Medline]
  2. Aggett PJ, Comerford JG: Zinc and human health. Nutr Rev 53: S16–22, 1995.[Medline]
  3. Karcioglu ZA: Zinc in the eye. Surv Ophthalmol 27: 114–122, 1982.[Medline]
  4. Groff JL, Gropper SS: ‘Advanced Nutrition and Human Metabolism.‘ Belmont: Wadsworth/Thompson Learning, pp 419–430, 2000.
  5. Walsh CT, Sandstead HH, Prasad AS, Newberne PM, Fraker PJ: Zinc:Health effects and research priorities for the 1990s. Environ Health Perspect 102: 5–46, 1994.
  6. Bettger WJ, O’Dell BL: Physiological roles of zinc in the plasma membrane of mammalian cells. J Nutr Biochem 4: 194–207, 1993.
  7. McMahon RJ, Cousins RJ: Mammalian zinc transporters. J Nutr 128: 667–670, 1998.[Abstract/Free Full Text]
  8. Vallee BL: The function of metallothionein. Neurochem Int 27: 23–33, 1995.[Medline]
  9. Gibson RS: Assessment of trace element status. In ‘Nutritional Assessment.‘ New York: Oxford University Press, pp 511–576, 1990.
  10. King JC: Assessment of zinc status. J Nutr 120: 1474–1479, 1990.
  11. Aggett PJ: Workshop on Assessment of zinc status. Proc Nutr Soc 50: 9–17, 1991.[Medline]
  12. Thompson RPH: Assessment of zinc status. Proc Nutr Soc 50: 19–28, 1991.[Medline]
  13. Wood RJ: Assessment of marginal zinc status in humans. J Nutr 130: 1350S–1354S, 2000.[Abstract/Free Full Text]
  14. O’Dell BL: Personal reflections on a galvanizing trail. Ann Rev Nutr 18: 1–18, 1998.[Medline]
  15. Berg JM, Shi Y: The galvanization of biology: a growing appreciation for the roles of zinc. Science 271: 1081–1085, 1996.[Abstract]
  16. Galin MA, Nano HD, Hall T: Ocular zinc concentration. Invest Ophthalmol Vis Sci 1: 142–148, 1962.[Abstract/Free Full Text]
  17. Eye Disease Case-Control Study Group: Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 110: 1701–1708, 1992.[Abstract]
  18. Newsome DA, Swartz M, Leone NC, Elston RC, Miller E: Oral zinc in macular degeneration. Arch Ophthalmol 106: 192–198, 1988.[Abstract]
  19. Yolton DP: Nutritional effects of zinc on ocular and systemic physiology. J Am Optom Assoc 52: 409–414, 1981.[Medline]
  20. Hirayama Y: Histochemical localization of zinc and copper in rat ocular tissues. Acta Histochem 89: 107–111, 1990.[Medline]
  21. Kohler T: Histochemical and cytochemical demonstration of zinc cysteinate in the tapetum lucidum of the cat. Histochemistry 70: 173–178, 1981.[Medline]
  22. Sturman JA, Wen GY, Wisniewski HM, Hayes KC: Histochemical localization of zinc in the feline tapetum: effect of taurine depletion. Histochemistry 72: 341–350, 1981.[Medline]
  23. Frederickson CJ, Kasarskis EJ, Ringo D, Frederickson RE: A quinolone fluorescence method for visualizing and assaying the histochemically reactive zinc (bouton zinc) in the brain. J Neurosci Meth 20: 91–103, 1987.[Medline]
  24. Danscher G: Histochemical demonstration of heavy metals. Histochemistry 71: 1–16, 1981.[Medline]
  25. Wu SM, Qiao X, Noebels JL, Yang XL: Localization and modulatory actions of zinc in vertebrate retina. Vision Res 33: 2611–2616, 1993.[Medline]
  26. Nishimura H, Nishimura N, Kobayashi S, Tohyama C: Immunohistochemical localization of metallothionein in the eye of rats. Histochemistry 95: 535–539, 1991.[Medline]
  27. Tate DJ, Newsome DA, Oliver PD: Metallothionein shows an age-related decrease in human macular retinal pigment epithelium. Invest Ophthalmol Vis Sci 34: 2348–2351, 1993.[Abstract/Free Full Text]
  28. Ulshafer RJ, Allen CB, Rubin ML: Distributions of elements in the human retinal pigment epithelium. Arch Ophthalmol 108: 113–119, 1990.[Abstract]
  29. Ulshafer RJ: Zinc content in melanosomes of degenerating RPE as measured by x-ray mapping. In Lavail MM, Anderson RE, Hollyfield JG (eds): ‘Inherited and Environmentally Induced Retinal Degenerations.‘ New York: Alan R. Liss, pp 131–139, 1989.
  30. Samuelson DA, Armstrong D, Jolly R: X-ray microprobe analysis of the retina and RPE in sheep with ovine ceroid-lipofuscinosis. Neurobiol Ageing 11: 663–667, 1990.
  31. Samuelson DA, Smith P, Ulshafer RJ, Hendricks DG, Whitley RD, Hendricks H, Leone NC: X-ray microanalysis of ocular melanin in pigs maintained on normal and low zinc diets. Exp Eye Res 56: 63–70, 1993.[Medline]
  32. Zalewski PD, Forbes IJ, Betts WH: Correlation of apoptosis with change in intracellular labile Zn(II) using Zinquin ((2-methyl-8-p-toluenesulphonamido-6-quinolyloxy)acetic acid), a new specific fluorescent probe for Zn(II). Biochem J 296: 403–408, 1993.
  33. Coyle P, Zalewski PD, Philcox JC, Forbes IJ, Ward AD, Lincoln SF, Mahadevan I, Rofe AM: Measurement of zinc in hepatocytes by using a fluorescent probe, zinquin: relationship to metallothionein and intracellular zinc. Biochem J 303: 781–786, 1994.
  34. Tam SW, Wilber KE, Wagner FW: Light sensitive zinc content of protein fractions from bovine rod outer segments. Biochem Biophys Res Commun 72: 302–309, 1976.[Medline]
  35. Shuster TA, Nagy AK, Conly, DC, Farber DB: Direct zinc binding to purified rhodopsin and disc membranes. Biochem J 282: 123–128, 1992.
  36. Wen GY, Wisniewski HM, Sturman JA: Hereditary abnormality in tapetum lucidum of the siamese eats: a histochemical and quantitative study. Histochemistry 75: 1–9, 1982.[Medline]
  37. Eckhert CD: Elemental concentrations in ocular tissues of various species. Exp Eye Res 37: 639–647, 1983.[Medline]
  38. Samuelson DA, Whitley RD, Hendricks DG, Hendricks H, Olson AE, Leone NC: Quantitative changes due to chronic low zinc diet in the pig. Invest Ophthalmol Vis Sci (Suppl) 30: 232, 1989.
  39. Samuelson DA, Swank A, Whitley RD, Gum GG, Lewis P, Hendricks DG, Hendricks H, Olson A, Leone NC: Morphological and morphometric effects of low-zinc diet on the young porcine eye. Prog Vet Comp Ophthalmol 3: 58–66, 1992.
  40. Oliver PD, Tate DJ, Newsome DA: Metallothionein in human retinal pigment epithelial cells: expression, induction and zinc uptake. Curt Eye Res 11: 183–188, 1992.
  41. Newsome DA, Rothman RJ: Zinc uptake in vitro by human retinal pigment epithelium. Invest Ophthalmol Vis Sci 28: 1795–1799, 1987.[Abstract/Free Full Text]
  42. Newsome DA, Oliver PD, Deupree DM, Miceli MV, Diamond JG: Zinc uptake by primate retinal pigment epithelium and choroid. Curr Eye Res 11: 213–217, 1992.[Medline]
  43. Anderson AR, Kastl PR, Karcioglu ZA: Comparison of aqueous humour and serum zinc levels in humans. British J Ophthalmol 71: 212–214, 1987.[Abstract/Free Full Text]
  44. Akyol N, Deger O, Keha EE, Kilic S: Aqueous humour and serum zinc and copper concentrations of patients with glaucoma and cataract. British J Ophthalmol 74: 661–662, 1990.[Abstract/Free Full Text]
  45. Shukla N, Moitra JK, Trivedi RC: Determination of lead, zinc, potassium, calcium, copper and sodium in human cataract lenses. Sci Total Environ 181: 161–165, 1996.[Medline]
  46. Starzycka M, Kowalska A, Kedziora M: Some inorganic constituents of the subretinal fluid. Ophthalmologica Basel 179: 220–224, 1979.
  47. Starzycka M, Kowalska A, Kedziora M: Application of atomic absorption spectrometry for the study of the subretinal fluid. Ophthalmologica Basel 180: 340–343, 1980.
  48. Murata T, Taura Y: Study of trace metallic elements in the lens. Ophthalmic Res 7: 8–14, 1975.
  49. Rasi V, Costantini S, Moramarco A, Giordano R, Giustolisi R, Gabrieli CB: Inorganic element concentrations in cataractous human lenses. Ann Ophthalmol 24: 459–464, 1992.[Medline]
  50. Stanojevic-Paovic A, Hristic V, Cuperlovic M, Jovanovic S, Krsmanovic J: Macro- and microelements in the cataractous eye lens. Ophthalmic Res 19: 230–234, 1987.[Medline]
  51. Bentley PJ, Grubb BR: Lateral spatial assay of zinc and superoxide dismutase in the ocular lens. Invest Ophthalmol Vis Sci 31: 153–155, 1990.[Abstract/Free Full Text]
  52. Bentley PJ, Grubb BR: Effects of zinc deficient diet on tissue zinc concentrations in rabbits. J Anim Sci 69: 4876–4882, 1991.[Abstract]
  53. Koumantakis E, Alexiou D, Grimanis A, Kaskarelis D, Bouzas A: Zinc, cobalt and selenium concentrations in the premature and full term newborn eye. Ophthalmologica Basel 186 41–46, 1983.
  54. Swanson AA, Truesdale AW: Elemental analysis in normal and cataractous human lens tissue. Biochem Biophys Res Comm 45: 1488–1496, 1971.[Medline]
  55. van der Schaft TL, de Bruijn WC, Mooy CM, Ketelaars DAM, de Jong PTVM: Element analysis of the early stages of age-related macular degeneration. Arch Ophthalmol 110: 389–394, 1992.[Abstract]
  56. Paterson PG, Grahn BH, Fabe JS: Retinal and lens zinc concentration in the zinc-deficient rat. FASEB J. 12: A521, 1998.
  57. Fabe J, Grahn BH, Paterson PG: Zinc concentrations of selected ocular tissues in zinc-deficient rats. Biol Trace Elem Res 75: 43–52, 2000.[Medline]
  58. Tjalve H, Frank A: Tapetum lucidum in the pigmented and albino ferret. Exp Eye Res 38: 341–351, 1984.[Medline]
  59. Tauber FW, Krause AC: The role of iron, copper, zinc, and manganese in the metabolism of the ocular tissues, with special reference to the lens. Am J Ophthalmol 26: 260–266, 1943.
  60. Rosenthal AR, Eckhert C: Copper and zinc in ophthalmology. In Karcioglu ZA, Sarper RM (eds): ‘Zinc and Copper in Medicine.‘ Springfield: Charles C. Thomas, pp 579–633, 1980.
  61. Bowness TM, Morton RA, Shakir MH, Stubbs AL: Distribution of copper and zinc in mammalian eyes. Occurrence of metals in melanin fractions from eye tissues. Biochem J 51: 530–535, 1952.[Medline]
  62. Wen GY, Sturman JA, Wisniewski HM, MacDonald A, Niemann WH: Chemical and ultrastructural changes in the tapetum of beagles with a hereditary abnormality. Invest Ophthalmol Vis Sci 23: 733–742, 1982.[Abstract/Free Full Text]
  63. Srivastava VK, Varshney N, Pandey DC: Role of trace elements in senile cataract. Acta Ophthalmologica 70: 839–841, 1992.[Medline]
  64. Ketola HG: Influence of dietary zinc on cataracts in rainbow trout (Salmo gairdneri). J Nutr 109: 965–969, 1979.
  65. Richardson NL, Higgs DA, Beames RM. McBride JR: Influence of dietary calcium, phosphorous, zinc, and sodium phytate level on cataract incidence, growth and histopathology in juvenile chinook salmon (Oncorhynchus tshawytscha). J Nutr 115: 553–567, 1985.
  66. Barash H, Poston HA, Rumsey GL: Differentiation of soluble proteins in cataracts caused by deficiencies of methionine, riboflavin or zinc in diets fed to Atlantic salmon (Salmo salar), rainbow trout (Salmo gairdneri) and lake trout (Salvelinus namaycush). Cornell Vet 72: 361–371, 1982.[Medline]
  67. Waagbo R, Bjerkas E, Sveier H, Breck O, Bjornestad E, Maage A: Nutritional status assessed in groups of smolting Atlantic salmon (Salmo salar L..), developing cataracts. J Fish Dis 19: 365–373, 1996.
  68. Bentley PJ, Chin B, Grubb B: Some observations on the zinc metabolism of the rabbit lens. Exp Eye Res 38: 497–507, 1984.[Medline]
  69. Rogers JM, Hurley LS: Effects of maternal zinc deficiency on development of the fetal rat retina. Teratology 29: 55a, 1984.
  70. Rogers JM, Hurley LS: Effects of zinc deficiency on morphogenesis of the fetal rat eye. Development 99: 231–238, 1987.[Abstract]
  71. Gottschall-Pass KT, Grahn BH, Gorecki DKJ, Paterson PG: Oscillatory potentials and light microscopic changes demonstrate an interaction between zinc and taurine in the developing rat retina. J Nutr 127: 1206–1213, 1997.[Abstract/Free Full Text]
  72. Gottschall-Pass KT, Grahn BH, Gorecki DKJ, Semple HA, Paterson PG: Depression of the electroretinogram in rats deficient in zinc and taurine during prenatal and postnatal life. J Nutr Biochem 9: 621–628, 1998.
  73. Sinning AR, Olson MD, Sandstead HH: The effects of zinc deficiency on developing photoreceptors in the rat retina: a scanning electron microscopic study. In O’Hare AMF (ed): ‘Scanning Electron Microscopy.‘ Chicago: SEM Inc., pp 867–873, 1984.
  74. Paterson PG, Grahn BH, Gottschall-Pass KT, Gorecki DKJ, Semple HA: Postnatal deficiencies of zinc and taurine alter electroretinograms, oscillatory potentials and morphology of the rat retina. Nutri Neurosci 2: 175–189, 1999.
  75. Leure-duPree AE: Electron-opaque inclusions in the rat retinal pigment epithelium after treatment with chelators of zinc. Invest Ophthalmol Vis Sci 21: 1–9, 1981.[Free Full Text]
  76. Leure-duPree AE, Bridges DB: Changes in retinal morphology and vitamin A metabolism as a consequence of decreased zinc availability. Retina 2: 294–302, 1982.[Medline]
  77. Leure-duPree AE, McClain CJ: The effect of severe zinc deficiency on the morphology of the rat retinal pigment epithelium. Invest Ophthalmol Vis Sci 23: 425–434, 1982.[Abstract/Free Full Text]
  78. Leure-duPree AE: Vascularization of the rat cornea after prolonged zinc deficiency. Anatomical Rec 216: 27–32, 1986.[Medline]
  79. Burns MS, Bellhorn RW, Impellizzeri CW, Aguirre GD, Laties AM: Development of hereditary tapetal degeneration in the beagle dog. Curr Eye Res 7: 103–114, 1988.[Medline]
  80. Jacobson SG, Meadows NJ, Keeling PWN, Mitchell WD, Thompson RPH: Rod mediated retinal dysfunction in cats with zinc depletion: comparison with taurine depletion. Clin Sci 71: 559–564, 1986.[Medline]
  81. Robertson BT, Burns MJ: Zinc metabolism and the zinc-deficiency syndrome in the dog. Am J Vet Res 24: 997–1002, 1963.[Medline]
  82. Samuelson DA, Lewis PA, MacKay E, Whitley RD: The influence of aging and low zinc nutrition on the choroid in the pig: I The melanocyte. Vet Ophthalmol 2: 27–34, 1999.[Medline]
  83. Samuelson DA, Lewis PA, MacKay E, Whitley RD: The influence of aging and low zinc nutrition on the choroid in the pig: II. The melanosome. Vet Ophthalmol 2: 35–45, 1999.[Medline]
  84. Nicolas MG, Fujiki K, Murayama K, Suzuki MT, Shindo N, Hotta Y, Iwata F, Fujimura T, Yoshikawa Y, Cho F, Kanai, A: Studies on the mechanism of early onset macular degeneration in cynomologus monkeys. II. Suppression of metallothionein synthesis in the retina in oxidative stress. Exp Eye Res 62: 399–408, 1996.[Medline]
  85. Olin KL, Morse LS, Murphy C, Paul-Murphy J, Line S, Bellhorn RW, Hjelmeland LM, Keen CL: Trace element status and free radical defense in elderly Rhesus Macaques (Macaca mulatta) with macular drusen. Proc Soc Exp Biol Med 208: 370–377, 1995.[Abstract]
  86. Wirsching Jr L: Eye symptoms in acrodermatitis enteropathica. Acta Ophthalmol 40: 567–574, 1962.
  87. Matta CS, Felker GV, Ide CH: Eye manifestations in acrodermatitis enteropathica. Arch Ophthalmol 93: 140–142, 1975.[Abstract]
  88. Racz P, Kovacs B, Varga L, Ujlaki, E, Zombai E, Karbuczky S: Bilateral cataract in acrodermatitis enteropathica. J Ped Ophthalmol Strabismus 16: 180–182, 1979.[Medline]
  89. Cameron JD, McClain CJ: Ocular histopathology of acrodermatitis enteropathica. British J Ophthalmol 70: 662–667, 1986.[Abstract/Free Full Text]
  90. Prabriputaloong A, Prakitrittranon W: Corneal involvelment in acrodermatitis enteropathica: a case report. J Med Assoc Thai 75: 423–427, 1992.[Medline]
  91. Muga SJ, Grider A: Partial characterization of a human zinc-deficiency syndrome by differential display. Biol Trace Elem Res 68: 1–12, 1999.[Medline]
  92. Pati SK, Mukherji R: Serum zinc in corneal ulcer - a preliminary report. Ind J Ophthalmol 39: 134–139, 1991.[Medline]
  93. Berman MB, Manabe R: Corneal collagenases: evidence for zinc metalloenzymes. Ann Ophthalmol 5: 1193–1209, 1973.[Medline]
  94. Yassur Y, Snir M, Melamed S, Ben-Sira I: Bilateral maculopathy simulating ‘cherry-red spot‘ in a patient with Crohn’s disease. Brit J Ophthalmol 65: 184–188, 1981.[Abstract/Free Full Text]
  95. McClain CJ, Su Le-Chu, Gilbert H, Cameron D: Zinc-defiency-induced retinal dysfunction in Crohn’s disease. Digest Dis Sci 28: 85–87, 1983.
  96. Karcioglu ZA, Stout R, Hahn HJ: Serum zinc levels in retinitis pigmentosa. Curr Eye Res 3: 1043–1048, 1984.[Medline]
  97. De Virgiliis S, Congia M, Turco MP, Frau F, Dessi C, Argiolu F, Sorcinelli R, Sitzia A, Cao A: Depletion of trace elements and acute ocular toxicity induced by desferrioxamine in patients with thalassaemia. Arch Dis Child 63: 250–255, 1988.[Abstract]
  98. Vinton NE, Heckenlively JR, Laidlaw SA, Martin DA, Foxman SR, Ament ME, Kopple JD: Visual function in patients undergoing long-term total parenteral nutrition. Am J Clin Nutr 52: 895–902, 1990.[Abstract/Free Full Text]
  99. Morrison SA, Russell RM, Carney EA, Oaks EV: Zinc deficiency: a cause of abnormal dark adaptation in cirrhotics. Am J Clin Nutr 31: 276–281, 1978.[Abstract/Free Full Text]
  100. Russell RM, Morrison SA, Smith FR, Oaks EV, Carney EA: Vitamin A reversal of abnormal dark adaptation in cirrhosis: study of effects on the plasma retinol transport system. Ann Intern Med 88: 622–626, 1978.
  101. Russell RM: Vitamin A and zinc metabolism in alcoholism. Am J Clin Nutr 33: 2741–2749, 1980.[Abstract/Free Full Text]
  102. Russell RM: Nutritional factors and dark adaptation. Retina 2: 303–304, 1982.[Medline]
  103. Russell RM, Cox ME, Solomons N: Zinc and the special senses. Ann Int Med 99: 227–239, 1983.
  104. McClain CJ. Antonow DR, Cohen DA, Shedlosfsky SI: Zinc metabolism in alcoholic liver disease. Alcoholism: Clin Exper Res 10: 582–589, 1986.
  105. Keeling PWN, O’Day J, Ruse W, Thompson RPH: Zinc deficiency and photoreceptor dysfunction in chronic liver disease. Clin. Sci 62: 109–111, 1982.[Medline]
  106. Vallee BL, Wacker WEC, Bartholomay AF, Robin E: Zinc metabolism in hepatic dysfunction. I New Engl J Med 255: 403–408, 1956.
  107. Vallee BL, Wacker WEC, Bartholomay AF, Hoch FL: Zinc Metabolism in hepatic dysfunction. II New Eng J Med 257: 1055–1065, 1957.
  108. Vallee BL, Falchuk KH: The biochemical basis of zinc physiology. Physiol Rev 73: 79–118, 1993.[Free Full Text]
  109. Prasad AS: Discovery of human zinc deficiency and studies in an experimental human model. Am J Clin Nutr 53: 403–412, 1991.[Abstract/Free Full Text]
  110. Prasad AS: Editorial: Zinc deficiency in humans: a neglected problem. J Am Coll Nutr 17: 542–543, 1998.[Free Full Text]
  111. Kulick MK, Hoffman CJ: Nutrition supplement usage recommendation by eye specialists for macular degeneration of the eye: a statewide survey of Michigan. Top Clin Nutr 10: 67–77, 1995.
  112. Stur M, Tittl M, Reitner A, Meisinger V: Oral zinc and the second eye in age-related macular degeneration. Invest Ophthalmol Vis Sci 37: 1225–1235, 1996.[Abstract/Free Full Text]
  113. Mares-Perlman JA, Klein R, Klein BEK, Greger JL, Brady WE, Palta M, Ritter LL: Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol 114: 991–997, 1996.[Abstract]
  114. Smith W, Mitchell P, Webb K, Leeder SR: Dietary antioxidants and age-related maculopathy. The Blue Mountains eye study. Ophthalmology 106: 761–767, 1999.
  115. VandenLangenberg GM, Mares-Perlman JA, Klein R, Klein BEK, Brady WE, Palta M: Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Study. Am J Epidemiol 148: 204–214, 1998.[Abstract/Free Full Text]
  116. Weiter JL: Macular degeneration. Is there a nutritional component. Editorial. Arch Ophthalmol 108: 183–184, 1988.
  117. Trempe CL: In reply. Arch Ophthalmol 111: 1023, 1993.[Medline]
  118. Age-related macular degeneration study group: Multicenter ophthalmic and nutritional age-related macular degeneration study-part 1: design, subjects and procedures. J Am Optometric Assoc 67: 12–29, 1996.
  119. Ciulla TA, Danis RP, Harris A: Age-related macular degeneration: A review of experimental treatments. Surv Ophthalmol 43: 134–146, 1998.[Medline]
  120. Chausmer AB. Zinc, insulin and diabetes. J Am Coll Nutr 17: 109–115, 1998.[Abstract/Free Full Text]
  121. Faure P, Benhamou PY, Perard A, Halimi S, Roussel AM: Lipid peroxidation in insulin dependent diabetic patients with early retinal degenerative lesions: effects of an oral zinc supplementation. Eur J Clin Nutr 49: 282–288, 1995.[Medline]
  122. Wu L, Massof RW, Starr SJ: Computer-assisted analysis of clinical electroretinographic intensity - response functions. Doc Ophthal Proc 37: 231–239, 1983.
  123. Pasantes-Morales H., Cruz, C: Protective effect of taurine and zinc on peroxidation-induced damage in photoreptor outer segments. J Neurosci Res 11: 303–311, 1984.[Medline]
  124. Smith JC: The vitamin A-zinc connection: a review. Ann. NY Acad. Sci 355: 62–75, 1980.[Abstract]
  125. McClain CJ, Kasarskis EJ, Allen JJ: Functional consequences of zinc deficiency. Prog Food Nutr Sci 9: 185–226, 1985.[Medline]
  126. Dorea JG, Olson JA: The rate of rhodopsin regeneration in the bleached eyes of zinc-deficient rats in the dark. J Nutr 116: 121–127, 1986.
  127. Smith J.C: Interrelationship of zinc and vitamin A metabolism in animal and human nutrition:a review. In Prasad AS, (ed): ‘Clinical, Biochemical and Nutritional Aspects of Trace Elements.‘ New York: Alan R Liss, pp 239–258, 1982.
  128. Huber AM, Gershoff SN: Effects of zinc deficiency on the oxidation of retinol and ethanol in rats. J Nutr 105: 1486–1490, 1975.
  129. Smith JE, Brown ED, Smith JC: The effect of zinc deficiency on the metabolism of retinol-binding protein in the rat. J Lab Clin Med 84: 692–697, 1974.[Medline]
  130. Kraft SP, Parker JA, Matuk Y, Venket Rao A: The rat electroretinogram in combined zinc and vitamin A deficiency. Invest Ophthalmol Vis Sci 28: 975–984, 1987.[Abstract/Free Full Text]
  131. Christian P, West Jr KP: Interactions between zinc and vitamin A: an update. Am J Clin Nutr 68: 435S–441S, 1998.[Abstract]
  132. Bok D: Retinal photoreceptor-pigment epithelium interactions. Invest Ophthalmol Vis Sci 26: 1659–1694, 1985.[Free Full Text]
  133. McCormick LD: Bound trace element content of bovine retinal disk membranes as determined by particle-induced X-ray emission. Biophys J 47: 381–385, 1985.[Abstract/Free Full Text]
  134. Takahashi T, Paliwal VK, Ebadi M: Subcellular distribution of zinc and the presence of a metallothionein-like protein in the bovine retina. Neurochem Int 13: 525–530, 1988.
  135. Shuster TA, Martin F, Nagy AK: Zinc causes an apparent increase in rhodopsin phosphorylation. Curr Eye Res 15: 1019–1024, 1996.[Medline]
  136. Shuster TA, Nagy AK, Farber DB: 8-azido-ATP({alpha}32P) binding to rod outer segment proteins. Exp Eye Res 46: 475–484, 1988.[Medline]
  137. Ou CZ, Ebadi M. Pineal and retinal protein kinase C isoenzymes: cooperative activation by calcium and zinc metallothionein. J Pinea